B-lineage acute lymphoblastic leukemia (ALL) is the commonest form of leukemia in children. Leukemic cells express morphologic, phenotypic and genotypic features which appear identical to those of B lymphocyte progenitors in normal bone marrow (BM). Normal immature B cells and cells from most cases of B-lineage ALL rapidly die in vitro unless they are supported by BM-derived stromal feeder layers. the long-term objective of this research is to define the similarities and differences between the growth requirements of normal B cell progenitors and their neoplastic counterparts. This goal will be attempted through three interrelated specific aims: 1) define the stromal cell types supporting normal and leukemic human immature B cells; 2) identify the growth factors that affect survival, proliferation and differentiation of these cells on stromal feeder layers; 3) determine the cells and molecules essential for adhesion of immature B cells to BM stromal layers. The hypothesis underlying this research is that leukemic B-cell precursors can expand in microenvironments inadequate to sustain their normal counterparts.
In Aim 1, the ability of BM stromal preparations grown under different culture conditions and of BM-derived stromal cell lines to support both normal and leukemic blast cells will be evaluated.
In Aim 2, the first question to be addressed is whether the beneficial effects of BM stromal layers are mediated through soluble, membrane-bound or matrix-bound growth factors. The identification of the essential growth factors for leukemic cells and for normal B cells at various maturative stages will be attempted by testing the effects of either adding cytokines to the cultures or neutralizing their activity with specific antibodies.
Aim 3 seeks to identify the adhesion molecules that play a central role in permitting the growth of normal and leukemic B- cell precursors on BM stromal layers, and to define the pattern of adhesion of normal B cells at various stages of maturation to different BM stromal cell components. The definition of the microenvironments that support normal and leukemic B-cell progenitors should increase understanding of B-cell ontogeny and leukemogenesis. It is also possible that new clinically relevant subgroups of patients will be identified on the basis of their in vitro growth requirements. The techniques established in this project should be applicable to in vitro models for testing of antileukemic agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058297-02
Application #
2098990
Study Section
Pathology B Study Section (PTHB)
Project Start
1993-02-01
Project End
1996-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Iwamoto, Shotaro; Mihara, Keichiro; Downing, James R et al. (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 117:1049-57
Imai, Chihaya; Iwamoto, Shotaro; Campana, Dario (2005) Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106:376-83
Imai, C; Campana, D (2004) Genetic modification of T cells for cancer therapy. J Biol Regul Homeost Agents 18:62-71
Imai, C; Mihara, K; Andreansky, M et al. (2004) Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 18:676-84
Mihara, Keichiro; Imai, Chihaya; Coustan-Smith, Elaine et al. (2003) Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 120:846-9
Pui, Ching-Hon; Relling, Mary V; Campana, Dario et al. (2002) Childhood acute lymphoblastic leukemia. Rev Clin Exp Hematol 6:161-80; discussion 200-2
Pui, Ching Hon; Relling, Mary V; Evans, William E (2002) Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 15:741-56
Suzuki, T; Coustan-Smith, E; Mihara, K et al. (2002) Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells. Leukemia 16:1276-84
Ito, C; Tecchio, C; Coustan-Smith, E et al. (2002) The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis. Leukemia 16:1344-52
Pui, C H (2001) Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol 38:13-21

Showing the most recent 10 out of 36 publications